Although some tumor has become a curable disease for many patients, involvement of the
central nervous system (CNS) is still a major concern. The blood–brain barrier (BBB), a …

Achieving effective drug delivery to traverse the blood–brain barrier (BBB) and target tumor
cells remains the greatest challenge for brain tumor therapy. Importantly, the overexpressed …

Addressing disorders related to the central nervous system (CNS) remains a complex
challenge because of the presence of the blood-brain barrier (BBB), which restricts the entry …

Recent research has highlighted the promising potential of cold atmospheric plasma (CAP)
in cancer therapy. However, variations in study outcomes are attributed to differences in …

Photodynamic therapy (PDT) is a promising add-on therapy to the current standard of care
for patients with glioblastoma (GBM). The traditional explanation of the anti-cancer PDT …

Gliomas are highly invasive and are the most common type of primary malignant brain
tumor. The routine treatments for glioma include surgical resection, radiotherapy, and …

Glioblastoma multiforme (GBM) is an aggressive brain cancer with high malignancy and
resistance to conventional treatments, resulting in a bleak prognosis. Nanoparticles offer a …

Glioblastoma (GBM) is a highly aggressive brain tumor, and its treatment is further
complicated by the high selectivity of the blood–brain barrier (BBB). The scientific community …

Targeted nanoparticles of different origins are considered as new-generation diagnostic and
therapeutic tools. However, there are no targeted drug formulations within the composition of …

Primary brain cancer or brain cancer is the overgrowth of abnormal or malignant cells in the
brain or its nearby tissues that form unwanted masses called brain tumors. People with …